Windlas Biotech Limited

NSEI:WINDLAS Stock Report

Market Cap: ₹20.0b

Windlas Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Windlas Biotech has a total shareholder equity of ₹4.7B and total debt of ₹151.6M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are ₹7.5B and ₹2.8B respectively. Windlas Biotech's EBIT is ₹666.4M making its interest coverage ratio 320.4. It has cash and short-term investments of ₹2.1B.

Key information

3.2%

Debt to equity ratio

₹151.63m

Debt

Interest coverage ratio320.4x
Cash₹2.13b
Equity₹4.71b
Total liabilities₹2.76b
Total assets₹7.47b

Recent financial health updates

No updates

Recent updates

There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Nov 20
There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Nov 01
Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Sep 01
Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 13
Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Jul 30
Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Jun 07
Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03
Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20
Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23
Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07
Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Financial Position Analysis

Short Term Liabilities: WINDLAS's short term assets (₹5.2B) exceed its short term liabilities (₹2.7B).

Long Term Liabilities: WINDLAS's short term assets (₹5.2B) exceed its long term liabilities (₹47.9M).

Debt to Equity History and Analysis

Debt Level: WINDLAS has more cash than its total debt.

Reducing Debt: WINDLAS's debt to equity ratio has reduced from 14.2% to 3.2% over the past 5 years.

Debt Coverage: WINDLAS's debt is well covered by operating cash flow (560.1%).

Interest Coverage: WINDLAS's interest payments on its debt are well covered by EBIT (320.4x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y